Senior Director

Revolution Medicines

Revolution Medicines

201-500 employees

Develops targeted therapies for RAS-addicted cancers.


$235,000 - $281,000


Senior, Expert

San Carlos, CA, USA

Required Skills
  • B.S. or M.S. in scientific fields with 15+ years of experience in clinical supply chain and logistics.
  • 5+ years of experience building and/or managing a clinical supply chain team.
  • Strong experience managing clinical supply activities for global phase 3, randomized, oncology clinical trials.
  • Working knowledge of import and export laws and processes.
  • Working knowledge of pharmaceutical drug product development and manufacturing.
  • Solid organizational and time management skills.
  • Effective, open, and transparent communication skills (verbal and written).
  • Capable of working on multiple projects/tasks and able to meet timelines.
  • Team-oriented, progressive thinker who enjoys participating in an innovative and creative work environment.
  • Lead a team to plan and deliver on-time, compliant clinical supply per the clinical development plan.
  • Collaborate with cross-functional teams to proactively identify and mitigate potential risks to the continued advancement of the clinical programs.
  • Serve as the clinical supply lead for assigned program(s) and develop/manage the clinical supply plan.
  • Lead and manage clinical supply and logistics activities, including demand forecasting and supply planning, IRT start-up and maintenance, label generation and approval, packaging and labeling operations, release and distribution, expiry extension, cold chain management, and inventory management.
  • Author, review, and/or approve related clinical and technical documents.
  • Lead vendor identification, selection, onboarding, and management for combo agent/comparator sourcing and secondary packaging and distribution.
  • Serve as a subject matter expert and develop continuous improvement plans for clinical supply GMP, GDP, and business processes.

REVOLUTION Medicines stands out in the oncology field for its unique approach to drug discovery, leveraging insights from nature and evolution to develop targeted therapies for RAS-addicted cancers. The company's robust drug discovery and medicinal chemistry capabilities have resulted in a deep pipeline of RAS inhibitors, with their most advanced product, RMC-4630, currently in a multi-cohort Phase 1/2 clinical program. This focus on genetic drivers and adaptive resistance mechanisms in cancer, coupled with their commitment to exploring mechanism-based dosing paradigms and in-pathway combinations, positions REVOLUTION Medicines as a leader in precision oncology.

Company Stage


Total Funding



Redwood City, California



Growth & Insights

6 month growth


1 year growth


2 year growth